NCT01254227View on ClinicalTrials.gov

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Cardiac Iron Overload
Interventions
DRUG

Deferasirox and Deferoxamine

Trial Locations (15)

10002

Novartis Investigative Site, Taipei

10330

Novartis Investigative Site, Bangkok

10700

Novartis Investigative Site, Bangkok

16128

Novartis Investigative Site, Genova

34093

Novartis Investigative Site, Istanbul

35040

Novartis Investigative Site, Izmir

80138

Novartis Investigative Site, Napoli

M5G 2C4

Novartis Investigative Site, Toronto

Unknown

Novartis Investigative Site, Cairo

GR-115 27

Novartis Investigative Site, Athens

265 04

Novartis Investigative Site, Patra - RIO

09121

Novartis Investigative Site, Cagliari

01330

Novartis Investigative Site, Adana

07070

Novartis Investigative Site, Antalya

NW1 2BU

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY